Makonen Belema
Bristol-Myers Squibb (United States)(US)
Publications by Year
Research Areas
Hepatitis C virus research, HIV/AIDS drug development and treatment, Hepatitis B Virus Studies, Biochemical and Molecular Research, Crystallization and Solubility Studies
Most-Cited Works
- → Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect(2010)931 cited
- → Discovery of Daclatasvir, a Pan-Genotypic Hepatitis C Virus NS5A Replication Complex Inhibitor with Potent Clinical Effect(2014)109 cited
- → Chiral Aziridinyl Radicals: An Application to the Synthesis of the Core Nucleus of FR-900482(1997)102 cited
- → Hepatitis C Virus NS5A Replication Complex Inhibitors: The Discovery of Daclatasvir(2014)87 cited
- → Enantiomer discrimination illustrated by high-resolution crystal structures of the human nuclear receptor hRARγ(2000)84 cited
- → Discovery and Development of Hepatitis C Virus NS5A Replication Complex Inhibitors(2014)73 cited
- → The effects of NS5A inhibitors on NS5A phosphorylation, polyprotein processing and localization(2011)60 cited
- → Synthesis and biological evaluation of 4-amino derivatives of benzimidazoquinoxaline, benzimidazoquinoline, and benzopyrazoloquinazoline as potent IKK inhibitors(2006)53 cited
- → Resensitizing daclatasvir-resistant hepatitis C variants by allosteric modulation of NS5A(2015)49 cited
- → Characterizations of HCV NS5A replication complex inhibitors(2013)47 cited